India – Roche Diagnostics launches cervical cancer screening lab in India

Cancer Institute (WIA) launched a molecular lab for cervical cancer screening on Wednesday.

Cancer Institute (WIA) launched a molecular lab for cervical cancer screening on Wednesday.
Roche Diagnostics India that provides in-vitro diagnostics solutions launched its HPV (Human Papilloma Virus) DNA screening solution at Cancer Institute. Persistent infection with high-risk HPV has been established to be the principal cause of cervical cancer in women, with HPV implicated in greater than 99 per cent of cervical cancers worldwide, a release said.

“It can take 10 to 15 years or longer for cervical cancer to develop. So regular screening to know a woman’s individual risk and finding disease early, before cancer develops, is an important prevention strategy.”…